Related references
Note: Only part of the references are listed.Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance
Eva Germovsek et al.
CLINICAL PHARMACOKINETICS (2019)
Integrative omics for health and disease
Konrad J. Karczewski et al.
NATURE REVIEWS GENETICS (2018)
Sunitinib induces hepatocyte mitochondrial damage and apoptosis in mice
Franziska Paech et al.
TOXICOLOGY (2018)
Cytotoxicity of 34 FDA approved small-molecule kinase inhibitors in primary rat and human hepatocytes
Jun Zhang et al.
TOXICOLOGY LETTERS (2018)
CYP2C9 and OATP1B1 genetic polymorphisms affect the metabolism and transport of glimepiride and gliclazide
Fayou Yang et al.
SCIENTIFIC REPORTS (2018)
Landscape of X chromosome inactivation across human tissues
Taru Tukiainen et al.
NATURE (2017)
Paritaprevir and Ritonavir Liver Concentrations in Rats as Assessed by Different Liver Sampling Techniques
Charles S. Venuto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Clinical trials in children
Pathma D. Joseph et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects
Valentina Franco et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
Kristin G. Ardlie et al.
SCIENCE (2015)
Regorafenib impairs mitochondrial functions, activates AMP-activated protein kinase, induces autophagy, and causes rat hepatocyte necrosis
Zuquan Weng et al.
TOXICOLOGY (2015)
Liver and peripheral blood concentration ratio (L/P) as a marker of postmortem drug redistribution: a literature review
Iain M. McIntyre
FORENSIC SCIENCE MEDICINE AND PATHOLOGY (2014)
NIH to balance sex in cell and animal studies
Janine A. Clayton et al.
NATURE (2014)
A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages
Ying Yu et al.
NATURE COMMUNICATIONS (2014)
Pharmacokinetics of Non-Intravenous Formulations of Fentanyl
Joern Loetsch et al.
CLINICAL PHARMACOKINETICS (2013)
Life Cycle Analysis of Kidney Gene Expression in Male F344 Rats
Joshua C. Kwekel et al.
PLOS ONE (2013)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M. Zanger et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Sex differences in kidney gene expression during the life cycle of F344 rats
Joshua C. Kwekel et al.
BIOLOGY OF SEX DIFFERENCES (2013)
Sex Differences in Drug Disposition
Offie P. Soldin et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
TRIAL WATCH Phase III and submission failures: 2007-2010
John Arrowsmith
NATURE REVIEWS DRUG DISCOVERY (2011)
Sex bias in neuroscience and biomedical research
Annaliese K. Beery et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
Hepatic Cytochrome P450s Attenuate the Cytotoxicity Induced by Leflunomide and Its Active Metabolite A77 1726 in Primary Cultured Rat Hepatocytes
Qiang Shi et al.
TOXICOLOGICAL SCIENCES (2011)
Disparate Inclusion of Older Adults in Clinical Trials: Priorities and Opportunities for Policy and Practice Change
Angelica P. Herrera et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2010)
Age and sex dependent changes in liver gene expression during the life cycle of the rat
Joshua C. Kwekel et al.
BMC GENOMICS (2010)
Pharmacokinetics and Pharmacodynamics of Tamsulosin in its Modified-Release and Oral Controlled Absorption System Formulations
Gabriela Franco-Salinas et al.
CLINICAL PHARMACOKINETICS (2010)
Males still dominate animal studies
Irving Zucker et al.
NATURE (2010)
Sex Differences in Pharmacokinetics and Pharmacodynamics
Offie P. Soldin et al.
CLINICAL PHARMACOKINETICS (2009)
Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes
David J. Waxman et al.
MOLECULAR PHARMACOLOGY (2009)
The challenges of clinical trials in the exclusion zone: The case of the frail elderly
Iman Ridda et al.
AUSTRALASIAN JOURNAL ON AGEING (2008)
The ontogeny of drug metabolism enzymes and implications for adverse drug events
Ronald N. Hines
PHARMACOLOGY & THERAPEUTICS (2008)
Clinical pharmacology in special populations: the extremes of age
Sarah N Hilmer et al.
Expert Review of Clinical Pharmacology (2008)
Serious adverse drug events reported to the food and drug administration, 1998-2005
Thomas J. Moore et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Predictive value of animal models for human cytochrome P450 (CYP)-mediated metabolism: A comparative study in vitro
M. Turpeinen et al.
XENOBIOTICA (2007)
Effect of CYP2C9 genetic polymorphisms on the efficacy and pharmacokinetics of glimepiride in subjecs with type 2 diabetes
Kazuko Suzuki et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2006)
Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes
MS Zhu et al.
DRUG METABOLISM AND DISPOSITION (2005)
Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate
DJ Greenblatt et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Cytochrome P4502C8 and flavin-containing monooxygenases are involved in the metabolism of tazarotenic acid in humans
M Attar et al.
DRUG METABOLISM AND DISPOSITION (2003)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors
D Williams et al.
CLINICAL PHARMACOKINETICS (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
